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Introduction
Breast cancer is the most common cancer diagnosis and 
the leading cause of cancer death among women in the 
world, with 1.7 million cases and 521,900 deaths estimated 
in 2012 [1]. The shape of age- specific incidence rates is 
similar across countries, although large differences exist 
in the absolute rates at every age, with fourfold variations 
between Western Europe and Asian regions. Furthermore, 
some studies reported that migrants assume the rates of 
the hosting populations in the following generations 
[2, 3]. These patterns are compatible with differences 
across populations in hormonal and reproductive factors, 
as well as lifestyle habits.
An early age at menarche—which implies the onset of 
a mature hormonal pattern, including onset of ovulation, 
cyclic hormonal changes, and menstruation—has been 
consistently related to an increased risk of breast cancer, 
with an estimated 5% of increase in risk for every year 
of menarche anticipation [4–6]. Alike, a late age at meno-
pause—which marks the cessation of ovulation and hor-
monal cycles—has been positively associated with breast 
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Abstract
Breast cancer is the most common cancer diagnosis and the leading cause of 
cancer death among women in the world, and differences across populations 
indicate a role of hormonal, reproductive and lifestyle factors. This study is 
based on a cohort of 78,050 women invited to undergo a mammogram by 
Local Health Authority of Milan, between 2003 and 2007. We carried out a 
nested case–control study including all the 3303 incident breast cancer cases 
diagnosed up to 2015, and 9909 controls matched by age and year of enroll-
ment. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) 
were estimated using logistic regression models. The ORs were 0.88 (95% CI: 
0.78–0.98) for an age at menarche ≥14 years and 1.39 (95% CI: 1.07–1.81) for 
an age of 30 years or older at first pregnancy. Body mass index (BMI) was 
positively associated with breast cancer risk in women older than 50 years 
(OR = 1.89, 95% CI: 1.54–2.31, for BMI≥30 vs. <20), while the association 
tended to be inverse in younger women. A high mammographic density increased 
breast cancer risk (OR = 2.61, 95% CI: 2.02–3.38 for density >75% vs. adipose 
tissue). The ORs were 1.67 (95% CI: 1.47–1.89) and 2.04 (95% CI: 1.38–3.00) 
for one first- degree relative and two or more relatives affected by breast cancer, 
respectively. Our study confirms the role of major recognized risk factors for 
breast cancer in our population and provides the basis for a stratification of 
the participants in the mammographic screening according to different levels 
of risk.
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cancer risk [4–6]. Nulliparous women have an increased 
risk of breast cancer, compared to parous ones, and among 
the latter, a younger age at first full- term pregnancy is 
associated with a lower risk [5, 6]. All the aforementioned 
aspects point to a role of the lifetime “dose” of exposure 
to endogenous hormones.
Another well- established risk factor for breast cancer 
is a family history of the disease in first- degree relatives, 
the risk being further increased in the presence of more 
than one affected relative [5–7].
Among lifestyle risk factors, alcohol drinking has been 
consistently related to breast cancer, with an increase in 
risk of about 20% for moderate drinkers and of 60% for 
heavy drinkers [5, 6, 8, 9], while the role of diet appears 
modest [9], with a weak inverse association with fiber 
intake [5, 6, 10], fruit, and fruit and vegetables combined, 
but not vegetables alone [5, 6, 11], and a weak positive 
association with total fat, if any [5, 6, 12].
In this study, we evaluated the role of hormonal fac-
tors, lifestyle habits, and family history of breast cancer, 
using data from a large cohort of women invited to par-
ticipate to a mammographic screening program in Italy. 
To our knowledge, this is the first study that quantified 
these associations in an Italian population participating 
to an organized a mammographic screening program.
Materials and Methods
Study population
This study is based on data from a cohort of 78,050 
women, aged between 41 and 76 years, resident in the 
municipality of Milan, who were invited to participate in 
the mammographic screening program of the Local Health 
Authority of Milan from 2003 to 2007 in the framework 
of a study with the acronym of FRiCaM (Risk Factors 
for Breast Cancer: Fattori di Rischio per il Carcinoma 
della Mammella), supported by a specific grant of the 
Italian League of Cancer Prevention.
All participants signed an informed consent and com-
pleted a self- administered questionnaire, developed with 
the aim to identify women at high risk of breast cancer, 
who may benefit from a high- intensity screening 
program.
A total of 131,246 women received a questionnaire while 
waiting for the mammographic exam: 71,398 of them 
completed the questionnaire (54%).
In order to obtain information from a sample of non-
screened women, 20,000 questionnaires were sent by mail 
to nonattenders to a mammographic screening: 6652 
women, who did not adhere to the mammographic screen-
ing, accepted to provide the questionnaire through postal 
delivery (33%).
The questionnaire requested detailed information on 
socio- demographic characteristics, anthropometric meas-
ures, menstrual and reproductive history, health status, 
family history of cancer (including breast), and lifestyle 
factors, including dietary habits. Mammographic density 
was available only for the sample of screened women and 
was read by experienced screening radiologists and clas-
sified in three categories: (1) almost entirely fat (less than 
25 percent glandular), (2) scattered fibroglandular densities 
or heterogeneously dense (approximately 25–75% glan-
dular), and (3) extremely dense (more than 75% 
glandular).
As all study participants provided a written informed 
consent together with the questionnaire, the date of the 
signing of the consensus was considered as the date of 
enrollment in the study. Breast cancer cases were identi-
fied through record linkage between the cohort and the 
Cancer Registry of Milan, which is active since 1999. This 
allowed to identify 3532 breast cancer cases diagnosed 
up to 2015. Among these, we excluded 229 women who 
had a date of diagnosis preceding the date of enrollment 
in the study. Thus, the final number of breast cancer 
cases included in this study is 3303. The study was approved 
by the Ethics Committee of the Local Health Authority 
of Milan. Record linkage with the Cancer Registry of 
Milan and with Civil Registry allowed to assess vital status 
and absence of cancer among the controls at the end of 
the follow- up period.
Nested case–control study
Within the screening cohort, we carried out a nested 
case–control study. All the 3303 incident breast cancer 
cases were included. For each case, three control subjects 
were chosen at random among cohort members alive and 
free of breast cancer, individually matched to cases by 
age (in quinquennia) and year of enrollment in the study. 
Thus, the present work is based on 3303 incident cases 
of breast cancer and 9909 matched controls.
Statistical analysis
We estimated odds ratios (ORs) and corresponding 95% 
confidence intervals (CIs) of breast cancer for the selected 
risk factors, through logistic regression models conditioned 
on age in quinquennia and year of enrollment, and adjusted 
for education (no/primary school, secondary/vocational 
school, high school, university), marital status (married/
cohabitant, separated/divorced, widow, never married), 
body mass index (<20, 20–24.9, 25–29.9, ≥30 kg/m2), 
alcohol drinking (never, >0–<1 drink/week, 1 drink/
week–<1 drink/day, 1 drink/day, >1 drink/day), age at 
menarche (≤11, 12–13, ≥14), age at first birth (<20, 20–24, 
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25–29, ≥30), menopausal status (premenopause, postmeno-
pause), family history of breast cancer (no, yes), when 
appropriate (i.e., when the factor was not considered as 
exposure variable). Women with a missing value for an 
exposure variable were excluded from the analysis of that 
variable, while women with missing values on a confound-
ing variable were included in the analyses, using a separate 
category for missing values. None of the confounding 
variables had missing values for more than 5% of both 
cases and controls. Regression analyses with ordered cat-
egories were used to test the presence of a linear trend.
All the analyses were performed using the SAS software, 
version 9.4 (SAS Institute, Inc., Cary, NC, USA).
Results
Table 1 shows the distribution of baseline socio- 
demographic characteristics of 3303 breast cancer cases 
and 9909 matched participants in the FRiCaM study. Cases 
tended to be more educated and were more likely never 
married, as compared to controls.
Table 2 provides the distribution of reproductive fac-
tors, health status and family history of breast cancer, 
and corresponding 95% ORs and CIs, among participants 
in the FRiCaM study. A higher age at menarche was 
associated with a reduced risk of breast cancer (OR = 0.88, 
95% CI: 0.78–0.98 for ≥14 years as compared to ≤11 years), 
with a significant trend of decrease in risk (P = 0.0265). 
A higher age at first live birth was associated with an 
increased risk of breast cancer (OR = 1.39, 95% CI: 
1.07–1.81 for ≥30 years vs. <20 years), with a significant 
trend in risk (P = 0.0006). Previous breast biopsies were 
associated with an increase in breast cancer risk 
(OR = 1.86, 95% CI: 1.63–2.12). Mammographic density 
was associated with breast cancer risk, the ORs being 
1.59 (95% CI: 1.31–1.93) for a density <25%, 2.25 (95% 
CI: 1.86–2.73) for 25–75%, and 2.61 (95% CI: 2.02–3.38) 
for >75%, as compared to almost entirely adipose tissue 
(P < 0.0001). Among women older than 50 years, cases 
were more frequently overweight (OR = 1.68, 95% CI: 
1.40–2.01) or obese (OR = 1.89, 95% CI: 1.54–2.31) as 
compared to women with a body mass index (BMI) <20 
(P for trend <0.0001), while among women younger than 
50 years BMI tended to be inversely related to breast 
cancer, though in the absence of statistical significance. 
Women who experienced a previous breast surgery had 
an increased risk of breast cancer (OR = 2.01, 95% CI: 
1.75–2.29). Family history of breast cancer in first- degree 
relatives was associated with an increased risk of breast 
cancer, the ORs being 1.67 (95% CI: 1.47–1.89) for women 
Table 1. Socio- demographic characteristics, and corresponding odds ratios (ORs) and 95% confidence intervals (CIs) of the participants in the FRiCaM 
study.
Cases 
N (%)
Controls 
N (%)
Crude OR (95% CI)
Age
<50 125 (3.78) 375 (3.78) —
50–54 549 (16.62) 1647 (16.62) —
55–59 732 (22.16) 2196 (22.16) —
60–64 872 (26.40) 2616 (26.40) —
65–69 700 (21.19) 2100 (21.19 —
≥70 325 (9.84) 975 (9.84) —
Year of enrollment
2003 787 (23.83) 2361 (23.83) —
2004 1558 (47.17) 4674 (47.17) —
2005 874 (26.46) 2622 (26.46) —
2006 68 (2.06) 204 (2.06) —
2007 16 (0.48) 48 (0.48) —
Education1
No/primary school 536 (16.48) 2070 (21.28) 1.002
Secondary/vocational school 1380 (42.42) 3917 (40.27) 1.37 (1.23–1.54)
High school 831 (25.55) 2335 (24.01) 1.40 (1.23–1.58)
University 506 (15.55) 1404 (14.44) 1.42 (1.23–1.64)
Marital status1
Married/cohabitant 2155 (67.41) 6657 (69.34) 1.002
Separated/divorced 289 (9.04) 876 (9.12) 1.02 (0.89–1.18)
Widow 427 (13.36) 1311 (13.65) 1.01 (0.89–1.14)
Never married 326 (10.20) 757 (7.88) 1.33 (1.16–1.53)
1The sum does not add up to the total because of missing values.
2Reference category.
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Table 2. Distribution of reproductive factors, health status and family history of breast cancer, and corresponding odds ratios (ORs) and 95% confi-
dence intervals (CIs) among the participants in the FRiCaM study.
Cases 
N (%)
Controls 
N (%)
OR (95% CI)1
Age at menarche (years)2
≤11 827 (25.66) 2355 (24.39) 1.003
12–13 1641 (50.92) 4750 (49.19) 1.00 (0.90–1.10)
≥14 755 (23.43) 2552 (26.43) 0.88 (0.78–0.98)
P for trend 0.0265
Age at first live birth (years)2
<20 83 (3.23) 337 (4.14) 1.003
20–24 751 (29.23) 2635 (32.36) 1.14 (0.88–1.47)
25–29 1077 (41.92) 3375 (41.44) 1.23 (0.95–1.60)
≥30 658 (25.61) 1797 (22.07) 1.39 (1.07–1.81)
P for trend 0.0006
Menopausal status
Premenopause 736 (22.28) 2191 (22.11) 1.003
Postmenopause 2567 (77.72) 7718 (77.89) 0.97 (0.86–1.10)
Oral contraceptives use2
Never 2003 (65.18) 6059 (65.74) 1.003
Ever 1070 (34.82) 3158 (34.26) 1.00 (0.91–1.10)
Hormone replacement therapy2
Never 2286 (73.72) 6717 (72.84) 1.003
Ever 815 (26.28) 2504 (27.16) 1.06 (0.96–1.17)
Previous breast biopsies2
No 2758 (87.28) 8817 (92.91) 1.003
Yes 402 (12.72) 673 (7.09) 1.86 (1.63–2.12)
Mammographic density2
Adipose 153 (5.15) 817 (9.00) 1.003
<25% 786 (26.45) 2780 (30.61) 1.59 (1.31–1.93)
25–75% 1160 (39.03) 3058 (33.67) 2.25 (1.86–2.73)
>75% 186 (6.26) 446 (4.91) 2.61 (2.02–3.38)
P for trend <0.0001
BMI in women ≤50 years (kg/m2)2
<20 39 (15.54) 107 (13.99) 1.001
20–24.9 138 (54.98) 400 (52.29) 0.90 (0.59–1.38)
25–29.9 56 (22.31) 187 (24.44) 0.75 (0.46–1.24)
≥30 18 (7.17) 71 (9.28) 0.70 (0.36–1.38)
P for trend 0.1803
BMI in women >50 years (kg/m2)2
<20 182 (6.12) 797 (8.94) 1.001
20–24.9 1414 (47.51) 4257 (47.76) 1.51 (1.27–1.80)
25–29.9 972 (32.66) 2771 (31.09) 1.68 (1.40–2.01)
≥30 408 (13.71) 1088 (12.21) 1.89 (1.54–2.31)
P for trend <0.0001
Previous diagnosis of other cancers2
No 2807 (94.70) 8397 (95.59) 1.003
Yes 157 (5.30) 387 (4.41) 1.19 (0.98–1.44)
Previous breast surgery2
No 2744 (87.17) 8823 (93.29) 1.003
Yes 404 (12.83) 635 (6.71) 2.01 (1.75–2.29)
Previous ovarian surgery2
No 2530 (85.16) 7543 (84.82) 1.003
Yes 441 (14.84) 1350 (15.18) 0.98 (0.87–1.10)
Previous Smear test2
No 2963 (93.06) 623 (6.55) 1.003
Yes 221 (6.94) 8884 (93.45) 0.94 (0.80–1.11)
Previous mammography2
No 135 (4.19) 432 (4.47) 1.003
Yes 3088 (95.81) 9241 (95.53) 1.04 (0.85–1.27)
Number of first- degree relatives affected by breast cancer
0 2817 (85.29) 9003 (90.86) 1.003
1 443 (13.41) 838 (8.46) 1.67 (1.47–1.89)
≥2 43 (1.30) 68 (0.69) 2.04 (1.38–3.00)
P for trend <0.0001
1Estimated through logistic regression models conditioned on age and year of enrollment, and adjusted for education, marital status, body mass 
 index, alcohol drinking, age at menarche, age at first birth, menopausal status, family history of breast cancer, when appropriate. Statistically signifi-
cant estimates are shown in bold.
2The sum does not add up to the total because of missing values.
3Reference category.
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with one relative affected by breast cancer and 2.04 (95% 
CI: 1.38–3.00) for women with two or more relatives 
affected by breast cancer (P for trend <0.0001). No sig-
nificant association was evident for the other considered 
factors, including menopausal status, oral contraceptives 
use, hormone replacement therapy use, previous diagnosis 
of other cancers, previous ovarian surgery, previous Smear 
test, and previous mammography.
Table 3 describes the association between lifestyle risk 
factors and breast cancer. Alcohol drinking was associated 
with an increased risk of breast cancer, the OR being 
1.21 (95% CI: 1.06–1.37) for >1 drink/week, as compared 
to never drinking (P for trend <0.0001). An inverse asso-
ciation was evident for fruit consumption (OR = 0.70, 
95% CI: 0.53–0.93 for >1 fruit per day vs. <1 fruit per 
week, P for trend = 0.0170). No significant association 
emerged for the remaining considered lifestyle factors, 
including tobacco smoking, consumption of vegetables, 
cheese, red and white meat, and fish.
Discussion
In the present study, we carried out a comprehensive 
assessment of the role of several hormonal and lifestyle 
factors for breast cancer, using data from a large cohort 
of women participating in a mammographic screening 
program in Italy. We observed a 12% reduced risk of 
developing breast cancer for women who had the menarche 
at 14 years old or after, and a 39% increased risk for 
women who had their first pregnancy at 30 years old or 
after. These results are in line with those from previous 
studies [4–6] and confirm the hormonal mechanisms 
implied in the onset of breast cancer. Age at menarche 
is related to the onset of ovulation, the later the age at 
menarche, the later the onset of ovulation and, possibly, 
of regular menstrual cycles [5, 13]. Moreover, some stud-
ies reported that hormonal levels throughout the whole 
reproductive years tend to be higher among women who 
have an earlier menarche [5, 14]. Independent of parity, 
an earlier age at full- term pregnancy is associated with 
a reduced risk of breast cancer [5, 6]. After menarche 
and before the first pregnancy, the breast has relatively 
undifferentiated ducts and alveolar buds, named lobule 
types 1 and 2. Then, the glandular epithelial cells gradu-
ally differentiate into lobule types 3 and 4. The differen-
tiation happens largely after the first pregnancy, and 
partially after subsequent pregnancies. Thus, when the 
first pregnancy occurs earlier, fewer cells are likely to 
have initiated the differentiation [5, 6]. These results con-
firm that lifetime exposure to hormones is involved in 
the development of the disease, the longer the hormonal 
exposure, the higher the risk of breast cancer [15].
As for the role of body weight on breast cancer risk, 
it was dependent on age—as a proxy of menopausal sta-
tus—in our, as well as in previous studies [5, 6], the 
association being inverse in premenopausal and positive 
in postmenopausal women. It has been suggested that in 
premenopause, obese women are less likely to ovulate, 
thus having reduced levels of circulating hormones. 
Conversely, after menopause, circulating estrogens derive 
mainly from adipose tissues, thus the higher the BMI, 
the higher the hormonal levels.
Mammographic density—that is, the overall percentage 
of dense tissue observed in the mammogram—has been 
consistently related to breast cancer risk and is modulated 
by hormonal, reproductive, and lifestyle risk factors asso-
ciated with the disease. Our observation of an increased 
risk of breast cancer associated with a higher mammo-
graphic density is in agreement with previous studies 
[5, 6, 16].
Our study also confirmed that breast cancer risk is 
higher among women with a family history of breast 
cancer, the increase in risk being 67% among women 
with a first- degree relative affected, and twofold in women 
with more than one relative affected by breast cancer. 
Several studies have reported this association, which may 
be due both to the fact that the relatives tend to be 
exposed to the same environmental and lifestyle factors, 
as well as to the fact that they share inheritable genetic 
susceptibility.
Considering lifestyle factors, we observed an increased 
risk of breast cancer among regular alcohol drinkers, which 
has been reported previously [5, 6, 8]. Different mecha-
nisms have been proposed to explain this association, 
including a direct carcinogenic effect of alcohol metabolites, 
an increase in circulating hormone levels, and an indirect 
effect as antagonist of folate [17, 18]. In our study, the 
increase in risk was 21% among drinkers of more than 
one drink per day, and 16% among drinkers of one drink 
per day. Given the high prevalence of moderate alcohol 
drinkers in our population, even a small increase in risk 
may be a relevant public health concern.
We did not observe any significant role of dietary habits, 
with the only exception of fruit consumption, which was 
inversely related to breast cancer risk. Although several 
studies have been carried out on the role of dietary habits 
on breast cancer etiology, this is still an open issue, and 
the evidence on specific foods or nutrients is controversial, 
with weak and inconsistent associations reported, if any 
[9, 19]. However, this finding may also be due to uncon-
trolled confounder, for example, physical activity, which 
is inversely related to breast cancer and is likely correlated 
with fruit intake [9].
Among the strengths of the present study, there are 
the population- based design, the large sample size, and 
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the use of prospectively collected data on several risk 
factors for breast cancer. Potential limitations arise from 
the use of a self- administered questionnaire, which is 
more prone to response bias, and the possibility of 
unmeasured and residual confounding, which cannot be 
completely ruled out. In particular, we did not have 
Table 3. Distribution of lifestyle risk factors, and corresponding 95% odds ratios (ORs) and confidence intervals (CIs) among the participants in the 
FRiCaM study.
Cases 
N (%)
Controls 
N (%)
OR (95% CI)1
Alcohol drinking (drinks/week)2
Never 508 (15.88) 1671 (17.44) 1.003
Occasional (>0–<1/week) 600 (18.76) 2056 (21.46) 0.91 (0.79–1.04)
1/week–<1/day 741 (23.17) 2239 (23.37) 1.03 (0.90–1.17)
1/day 388 (12.13) 1104 (11.52) 1.16 (1.00–1.36)
>1/day 961 (30.05) 2510 (26.20) 1.21 (1.06–1.37)
P for trend <0.0001
Tobacco smoking2
Never 1834 (57.08) 5338 (55.90) 1.003
Ex 707 (22.00) 2144 (22.45) 0.91 (0.82–1.00)
Current 672 (20.92) 2067 (21.65) 0.92 (0.83–1.02)
P for trend 0.0681
Dietary habits
Vegetable intake2
<1/week 50 (1.56) 159 (1.65) 1.003
1–6/week 768 (23.91) 2390 (24.82) 1.00 (0.72–1.39)
1/day 1014 (31.57) 2981 (30.96) 1.01 (0.73–1.41)
>1/day 1380 (42.96) 4098 (42.56) 0.97 (0.70–1.35)
P for trend 0.5829
Fruit intake2
<1/week 73 (2.29) 167 (1.75) 1.003
1–6/week 381 (11.96) 1105 (11.56) 0.75 (0.56–1.02)
1/day 717 (22.50) 2050 (21.45) 0.76 (0.57–1.02)
>1/day 2015 (63.25) 6235 (65.24) 0.70 (0.53–0.93)
P for trend 0.0170
Cheese intake2
<1/week 219 (7.06) 696 (7.41) 1.003
1–3/week 1674 (54.00) 5054 (53.82) 1.04 (0.89–1.23)
4–6/week 540 (17.42) 1565 (16.67) 1.07 (0.89–1.28)
≥1/day 667 (21.52) 2075 (22.10) 1.01 (0.85–1.21)
P for trend 0.8673
Red meat intake2
<1/week 810 (25.67) 2426 (25.77) 1.003
1/week 1013 (32.10) 3022 (32.10) 1.01 (0.90–1.12)
2–3/week 1007 (31.91) 3113 (33.07) 0.97 (0.87–1.08)
≥4/week 326 (10.33) 852 (9.05) 1.12 (0.96–1.31)
P for trend 0.5767
White meat intake2
<1/week 395 (12.48) 1300 (13.68) 1.003
1/week 858 (27.11) 2664 (28.03) 1.06 (0.93–1.22)
2–3/week 1508 (47.65) 4327 (45.53) 1.14 (1.00–1.30)
≥4/week 404 (12.76) 1212 (12.75) 1.09 (0.92–1.28)
P for trend 0.1101
Fish intake2
<1/week 938 (29.34) 2865 (29.87) 1.003
1/week 1223 (38.25) 3674 (38.30) 1.01 (0.91–1.11)
2–3/week 874 (27.34) 2625 (27.37) 0.99 (0.89–1.10)
≥4/week 162 (5.07) 428 (4.46) 1.10 (0.90–1.34)
P for trend 0.7700
1Estimated through logistic regression models conditioned on age and year of enrollment, and adjusted for education, marital status, body mass 
index, alcohol drinking, age at menarche, age at first birth, menopausal status, family history of breast cancer, when appropriate. Statistically signifi-
cant estimates are shown in bold.
2The sum does not add up to the total because of missing values.
3Reference category.
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information on physical activity, which is known to 
decrease breast cancer risk. Moreover, participants in a 
screening program may be not completely representative 
of the general population, having healthier lifestyle habits 
and being more health conscious than women who did 
not undergo the screening. However, the associations 
observed in the present study are generally consistent 
with the literature, thus reassuring against any major 
differential misclassification.
Thus, our study confirms the role of major recognized 
risk factors for breast cancer—including age at menarche, 
age at first pregnancy, alcohol drinking, and BMI (with 
a differential role according to menopausal status)—which 
are used in predictive models to estimate the individual 
absolute risk to develop breast cancer [20, 21]. In addi-
tion, we observed an increased risk associated with a 
higher mammographic density. This is the first study that 
assessed these associations in an Italian population under-
going a mammographic screening. These findings will be 
helpful to develop a predictive model for breast cancer 
risk, focused on the Italian population, providing the basis 
for a stratification of the population according to different 
levels of risk, in order to offer differentiate screening 
procedure and timing.
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